Deltec Asset Management LLC Ocular Therapeutix, Inc Transaction History

Deltec Asset Management LLC

$491 Million
Q1 2024

A detailed history of Deltec Asset Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Deltec Asset Management LLC holds 2,364,084 shares of OCUL stock, worth $16.2 Million. This represents 4.38% of its overall portfolio holdings.

Number of Shares

2,364,084

Previous 2,443,607 3.25%

Holding current value

$16.2 Million

Previous $10.9 Million 97.4%

% of portfolio

4.38%

Previous 2.51%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$3.85 - $10.93 $306,163 - $869,186	-79,523 Reduced 3.25%	2,364,084 $21.5 Million
Q4 2023 Jan 22, 2024	BUY	$2.08 - $4.52 $794,164 - $1.73 Million	381,810 Added 18.52%	2,443,607 $10.9 Million
Q3 2023 Oct 23, 2023	BUY	$3.14 - $5.04 $273,180 - $438,480	87,000 Added 4.41%	2,061,797 $6.47 Million
Q2 2023 Jul 18, 2023	BUY	$4.6 - $7.64 $281,451 - $467,453	61,185 Added 3.2%	1,974,797 $10.2 Million
Q1 2023 Apr 17, 2023	BUY	$2.79 - $6.27 $169,260 - $380,382	60,667 Added 3.27%	1,913,612 $10.1 Million

Q4 2022 Jan 25, 2023	SELL	$2.61 - $4.41 $1.23 Million - $2.08 Million	-470,728 Reduced 20.26%	1,852,945 $0
Q3 2022 Oct 26, 2022	BUY	$4.09 - $6.5 $1.04 Million - $1.65 Million	254,360 Added 12.29%	2,323,673 $9.64 Million
Q2 2022 Jul 18, 2022	SELL	$3.01 - $5.22 $21,070 - $36,540	-7,000 Reduced 0.34%	2,069,313 $8.32 Million
Q1 2022 Apr 11, 2022	SELL	$4.83 - $7.35 $91,770 - $139,650	-19,000 Reduced 0.91%	2,076,313 $10.3 Million
Q4 2021 Jan 25, 2022	SELL	$6.16 - $12.07 $332,640 - $651,780	-54,000 Reduced 2.51%	2,095,313 $14.6 Million
Q3 2021 Oct 13, 2021	SELL	$9.7 - $14.34 $174,600 - $258,120	-18,000 Reduced 0.83%	2,149,313 $21.5 Million
Q2 2021 Jul 15, 2021	BUY	$13.43 - $19.16 $953,153 - $1.36 Million	70,972 Added 3.39%	2,167,313 $30.7 Million
Q1 2021 Apr 21, 2021	SELL	$15.82 - $22.11 $1.14 Million - $1.6 Million	-72,232 Reduced 3.33%	2,096,341 $34.4 Million
Q4 2020 Jan 20, 2021	SELL	$7.91 - $22.95 $2.4 Million - $6.97 Million	-303,494 Reduced 12.28%	2,168,573 $44.9 Million
Q3 2020 Oct 23, 2020	BUY	$7.36 - $9.87 $1.04 Million - $1.4 Million	141,800 Added 6.09%	2,472,067 $18.8 Million
Q2 2020 Jul 29, 2020	BUY	$4.67 - $8.95 $1.2 Million - $2.3 Million	256,548 Added 12.37%	2,330,267 $19.4 Million
Q1 2020 Apr 22, 2020	SELL	$3.95 - $7.4 $194,889 - $365,108	-49,339 Reduced 2.32%	2,073,719 $10.3 Million
Q4 2019 Jan 27, 2020	BUY	$2.57 - $4.73 $294,455 - $541,935	114,574 Added 5.7%	2,123,058 $8.39 Million
Q3 2019 Oct 24, 2019	BUY	$3.04 - $5.32 $1.8 Million - $3.15 Million	592,237 Added 41.82%	2,008,484 $6.11 Million
Q2 2019 Jul 29, 2019	BUY	$2.46 - $4.52 $1.46 Million - $2.67 Million	591,500 Added 71.72%	1,416,247 $6.23 Million
Q1 2019 Apr 22, 2019	BUY	$3.51 - $4.77 $351,000 - $476,999	100,000 Added 13.8%	824,747 $3.27 Million
Q4 2018 Jan 23, 2019	BUY	$3.87 - $7.11 $405,583 - $745,142	104,802 Added 16.91%	724,747 $2.89 Million
Q3 2018 Oct 18, 2018	BUY	$5.42 - $6.99 $471,317 - $607,843	86,959 Added 16.32%	619,945 $4.27 Million
Q2 2018 Aug 07, 2018	SELL	$5.99 - $8.17 $318,985 - $435,077	-53,253 Reduced 9.08%	532,986 $3.6 Million
Q1 2018 May 11, 2018	BUY	$4.66 - $7.08 $1.73 Million - $2.63 Million	372,000 Added 173.64%	586,239 $3.82 Million
Q4 2017 Feb 05, 2018	SELL	$3.73 - $6.37 $356,095 - $608,131	-95,468 Reduced 30.83%	214,239 $953,000
Q3 2017 Oct 30, 2017	BUY	$5.28 - $6.88 $1.64 Million - $2.13 Million	309,707	309,707 $1.91 Million

Others Institutions Holding OCUL

# of Institutions

148

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.

Account

Deltec Asset Management LLC Ocular Therapeutix, Inc Transaction History